
Please try another search
Breaking News
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.250 | 2.250 | 0.000 |
Stocks | 97.610 | 97.610 | 0.000 |
Other | 0.140 | 0.140 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.215 | 19.026 |
Price to Book | 7.281 | 3.274 |
Price to Sales | 5.521 | 2.332 |
Price to Cash Flow | 20.637 | 12.824 |
Dividend Yield | 1.122 | 1.983 |
5 Years Earnings Growth | 12.335 | 10.993 |
Name | Net % | Category Average |
---|---|---|
Technology | 43.490 | 20.216 |
Healthcare | 37.790 | 13.021 |
Communication Services | 18.720 | 9.223 |
Number of long holdings: 33
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 8.85 | 175.46 | +1.76% | |
NVIDIA | US67066G1040 | 8.60 | 98.30 | +2.08% | |
Alphabet A | US02079K3059 | 8.04 | 144.01 | -0.48% | |
Microsoft | US5949181045 | 7.75 | 356.94 | +0.67% | |
Meta Platforms | US30303M1027 | 6.00 | 508.68 | -0.35% | |
Eli Lilly | US5324571083 | 5.40 | 700.00 | -3.61% | |
UnitedHealth | US91324P1021 | 4.94 | 564.01 | +1.98% | |
Roche Holding Participation | CH0012032048 | 4.62 | 235.30 | -5.88% | |
Novartis | CH0012005267 | 4.37 | 82.36 | -7.08% | |
Thermo Fisher Scientific | US8835561023 | 3.84 | 412.22 | -1.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIBC Nasdaq Index | 3.22B | -0.07 | 18.10 | 17.95 | ||
CIBC Nasdaq Index Premium Class | 3.22B | 0.06 | 19.06 | 18.96 | ||
CIBC US Broad Market Index | 2.28B | 1.57 | 14.81 | 12.29 | ||
CIBC US Broad Market Index Premium | 2.28B | 1.69 | 15.66 | 13.15 | ||
CIBC Managed Growth Portfolio T8 | 36.26M | 2.53 | 6.43 | 6.41 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review